Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Geschäft · 12.7.20191 Min. Lesezeit
Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients; Public Workshop; Cancellation
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration is announcing the cancellation of a public workshop entitled "Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients" that was previously scheduled for August 8, 2019, from 8:30 a.m. to 4:30 p.m. This public workshop was announced in the Federal Register of May 2, 2019. The meeting has been cancelled due to unforeseen changes in the adenovirus drug development landscape.
Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →